Dyne Therapeutics, Inc. DYN Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s common stock?
- Dyne Therapeutics, Inc. (DYN) reported common stock of $16K in Q1 2026.
- How has Dyne Therapeutics, Inc.'s common stock changed year-over-year?
- Dyne Therapeutics, Inc.'s common stock increased by 45.5% year-over-year, from $11K to $16K.
- What is the long-term trend for Dyne Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s common stock has grown at a 26.2% compound annual growth rate (CAGR), from $5K to $16K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).